Location History:
- P.O. Box 1539, King of Prussia, PA (US) (1998)
- Natick, MA (US) (1995 - 2013)
Company Filing History:
6 out of 72 
1 out of 517 
1 out of 832,812 Years Active: 1995-2013
Title: The Innovative Contributions of Steven E. Shoelson
Introduction
Steven E. Shoelson, a prominent inventor based in Natick, MA, has made significant strides in the medical field with his innovative approaches to treating metabolic disorders. With a portfolio of 7 patents, Shoelson's work primarily focuses on the alarming rise of type 2 diabetes and related conditions.
Latest Patents
Among Shoelson's latest patents are groundbreaking inventions aimed at combating type 2 diabetes. One notable patent involves methods for reducing chronic subacute inflammatory states linked to obesity, enhancing glycemia to prevent or delay the onset of type 2 diabetes in obese individuals and those with metabolic syndrome. This invention utilizes non-acetylated forms of salicylate, such as salsalate or trilisate.
Another significant patent pertains to a method for identifying compounds that treat insulin resistance. This invention outlines a process for evaluating compounds or agents that can bind or modulate IKK-β activity, thereby pinpointing potential treatments for disorders characterized by insulin resistance. Additionally, the patent includes compounds identified using these methods and outlines treatment methodologies for subjects affected by such conditions.
Career Highlights
Throughout his career, Steven E. Shoelson has been associated with prestigious institutions such as the Joslin Diabetes Center. His groundbreaking research at these organizations has contributed substantially to the scientific community's understanding of diabetes and metabolism.
Collaborations
Shoelson has collaborated with esteemed professionals in his field, including George S. Eisenbarth and Luis Castano. Their collective expertise has likely fostered an environment of innovation, further enhancing the impact of their work in addressing complex metabolic disorders.
Conclusion
Steven E. Shoelson exemplifies the spirit of innovation through his patents and contributions to diabetes research. His efforts are pivotal in developing new treatment strategies for insulin resistance and type 2 diabetes, and they serve to inspire future advancements in medical science.